Novartis trial validates inflammasome as chronic disease driver

Nature Biotechnology 35, 893 (2017).
doi:10.1038/nbt1017-893

Author: Cormac Sheridan

Source: Nature Biotechnology - October 11, 2017 Category: Biotechnology Authors: Cormac Sheridan Tags: News Source Type: research